Literature DB >> 10778759

Validation of the modified TNM-Izumi classification for hepatocellular carcinoma.

C Staudacher1, A Chiappa, F Biella, R A Audisio, E Bertani, A P Zbar.   

Abstract

AIMS AND
BACKGROUND: The clinical value of the UICC TNM classification and the Izumi TNM modification regarding prognosis after hepatic resection was evaluated.
METHODS: Between January 1993 and December 1998, survival and disease-free survival were analyzed in 53 cirrhotic patients (40 males, 13 females; mean age, 65 years; range, 43-81) who underwent hepatic resection for HCC.
RESULTS: The 1-, 3-, and 5-year overall survivals were: 89%, 54%, and 50%, with disease-free survivals of 70%, 38%, and 28%, respectively. The difference between stages 1 and 2 or stages 3 and 4A using the UICC TNM classification was not significant with respect to survival or disease-free survival. Conversely, the Izumi TNM modification showed a significant difference between each stage with respect to survival and disease-free survival. In a multivariate analysis the lack of micro/macro vascular invasion was predictive of long-term outcome.
CONCLUSIONS: Our results show that the UICC TNM classification for hepatocellular carcinoma is inadequate. The Izumi modified TNM staging system is superior in assessing prognosis for surgical HCC patients.

Entities:  

Mesh:

Year:  2000        PMID: 10778759     DOI: 10.1177/030089160008600102

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  4 in total

1.  Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.

Authors:  I Levy; M Sherman
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Small hepatocellular carcinoma: current and future approaches.

Authors:  Wen-Ming Cong; Meng-Chao Wu
Journal:  Hepatol Int       Date:  2013-08-06       Impact factor: 6.047

3.  Tumor size is a major determinant of prognosis of resected stage I hepatocellular carcinoma.

Authors:  Wei-Ju Huang; Yung-Ming Jeng; Hong-Shiee Lai; Fang-Yu Bonnie Sheu; Po-Lin Lai; Ray-Hwang Yuan
Journal:  Langenbecks Arch Surg       Date:  2015-08-07       Impact factor: 3.445

4.  Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.

Authors:  Masami Minagawa; Iwao Ikai; Yutaka Matsuyama; Yoshio Yamaoka; Masatoshi Makuuchi
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.